Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hepatobiliary Cancers × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1179 Carcinoma, Hepatocellular 691 Stomach Neoplasms 633 Pancreatic Neoplasms 611 Colonic Neoplasms 470 Rectal Neoplasms 421 Esophageal Neoplasms 382 Liver Neoplasms 281 Neoplasms 234 Breast Neoplasms 194 Lung Neoplasms 163 Gastrointestinal Neoplasms 147 Cholangiocarcinoma 136 Barrett Esophagus 108 Prostatic Neoplasms 98 Neoplasm Metastasis 90 Ovarian Neoplasms 81 Carcinoma, Non-Small-Cell Lung 72 Anus Neoplasms 71 Disease 62 Biliary Tract Neoplasms 62 Melanoma 61 Gastrointestinal Stromal Tumors 60 Esophageal Squamous Cell Carcinoma 59 Head and Neck Neoplasms 58 Colorectal Neoplasms, Hereditary Nonpolyposis 57 Liver Cirrhosis 55 Gallbladder Neoplasms 53 Recurrence 51 Uterine Cervical Neoplasms 50

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06252753 2025-12-26

LIVER-R

AstraZeneca

Gastrointestinal

Hepatobiliary Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡